Rare diseases
Investigational molecules
Locations
Suite 2 Level 11, 385 Bourke Street, 3000
Prescient Therapeutics Limited focuses on clinical research in cutaneous T-cell lymphoma, with activity centered on treatment options for patients with relapsed or refractory disease. The sponsor’s trial portfolio reflects interest in haematologic malignancy care, particularly T-cell lymphoma management and disease control in advanced skin-involved lymphoproliferative disorders.
Its research activity is directed toward clinical evaluation of therapies intended for patients with limited treatment options in this rare oncology setting.
Prescient Therapeutics Limited runs clinical trials in conditions such as Cutaneous T-cell lymphoma recurrent, Cutaneous T-cell lymphoma refractory, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
